<DOC>
	<DOCNO>NCT02995083</DOCNO>
	<brief_summary>To investigate clinical benefit intra-articular injection saline patient symptomatic osteoarthritis knee compare clinical response saline current standard treatment corticosteroid air injection placebo .</brief_summary>
	<brief_title>Intra-articular Injections Knee Osteoarthritis : A Single Blinded Prospective Randomized Trial</brief_title>
	<detailed_description>As non-surgical treatment OA essential , multiple trial do compare standard care IA injection therapy novel injection treatment , many trial use saline control arm . The purpose use control arm attempt eliminate placebo effect help distinguish true effectiveness therapy . There controversy clinical effect saline treat OA argue saline may clinical benefit . If true , could allow true effect standard care therapy appear diminish compare saline placebo . A recent meta analysis look use saline placebo 38 randomize control trial determine intra-articular saline injection knee OA clinical effect . The study find IA injection saline significantly improve short-term knee pain 32 study involve 1705 patient , p &lt; 0.001 , long-term pain significantly decrease 19 study involve 1445 patient , p &lt; 0.001 . It essential empirically determine saline clinical effect due role play placebo many clinical study management OA intra-articular injection . Objective : To investigate clinical benefit intra-articular injection saline patient symptomatic osteoarthritis knee compare clinical response saline current standard treatment corticosteroid air injection placebo . Study Design : Prospective , single-blinded , randomize , clinical study . Patients randomize three treatment arm 1:1:1 fashion approximately 50 patient saline arm , 50 patient corticosteroid arm , 50 patient placebo arm . Null Hypothesis : Clinical knee outcomes subject follow one intra-articular knee injection air similar one intra-articular knee injection saline corticosteroid symptomatic patient diagnose knee OA . Statistical Assumptions : Power Analysis Investigational Arm : 10 ml Saline ( Normal Saline ) Control Arm : 1 ml 40 mg corticosteroid 9 ml 1 % lidocaine ( Depo-medrol , Pfizer , New York , New York ) , 10 ml air ( placebo ) Primary Efficacy Endpoint : The primary efficacy endpoint mean change WOMAC Index score 12 week first injection regard baseline score . Secondary Efficacy Secondary efficacy endpoint include change full Endpoints : WOMAC Index , KOOS , Lysholm , IKDC , VAS , SF-12 use rescue medication ( steroid 12 week ) . Enrollment : Prospective , randomize , clinical study design evaluate 150 subject . All enrolled subject pre-procedure visit , one treatment visit , follow-up visit week 6 week 12 require rescue injection fill patient report outcome measure 1 , 6 , 12 , 24 week .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>1 . The patient must age 18 80 2 . Informed consent obtain patient 3 . The patient must diagnose symptomatic osteoarthritis tibiofemoral patellofemoral compartment target knee least 1 month 4 . The patient moderatetosevere knee pain reflected average visual analogue scale ( VAS ) score 4 great ( possible 10 ) previous 7 day . 5 . Radiographic image must show grade IIIII osteoarthritis Kellgren &amp; Lawrence Scale . 6 . Patients may bilateral osteoarthritis patient unilateral symptom may include . 1 . Knee instability 2 . A score less 4 ( possible 10 ) intake VAS 3 . Major axial deviation ( &gt; 5ยบ valgus varus deviation evidence standard care xray . 4 . Previous surgery target knee &lt; 6 month . 5 . Symptomatic osteoarthritis contralateral knee joint . 6 . Systemic intra articular injection joint corticosteroid within 6 month prior screen 7 . Previous joint injection type past 6 month 8 . Systemic condition could interfere outcome Rheumatoid arthritis , coagulopathy , anemia . 9 . Allergy inject substance . 10 . Any patient unable cease NSAID usage ( low dose aspirin ) due unrelated condition . 11 . Cognitive impairment unable provide inform consent 12 . Recent knee trauma violation intraarticular bone .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>osteoarthritis</keyword>
</DOC>